314 related articles for article (PubMed ID: 24239602)
1. Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts.
Tank J; Lindner D; Wang X; Stroux A; Gilke L; Gast M; Zietsch C; Skurk C; Scheibenbogen C; Klingel K; Lassner D; Kühl U; Schultheiss HP; Westermann D; Poller W
J Mol Cell Cardiol; 2014 Jan; 66():141-56. PubMed ID: 24239602
[TBL] [Abstract][Full Text] [Related]
2. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
3. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
4. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
[TBL] [Abstract][Full Text] [Related]
5. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
[TBL] [Abstract][Full Text] [Related]
6. CTGF/CCN2 is an autocrine regulator of cardiac fibrosis.
Dorn LE; Petrosino JM; Wright P; Accornero F
J Mol Cell Cardiol; 2018 Aug; 121():205-211. PubMed ID: 30040954
[TBL] [Abstract][Full Text] [Related]
7. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program.
Nakerakanti SS; Kapanadze B; Yamasaki M; Markiewicz M; Trojanowska M
J Biol Chem; 2006 Sep; 281(35):25259-69. PubMed ID: 16829517
[TBL] [Abstract][Full Text] [Related]
8. CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β.
Xu H; Li P; Liu M; Liu C; Sun Z; Guo X; Zhang Y
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1207-19. PubMed ID: 26218313
[TBL] [Abstract][Full Text] [Related]
9. Silencing CTGF/CCN2 inactivates the MAPK signaling pathway to alleviate myocardial fibrosis and left ventricular hypertrophy in rats with dilated cardiomyopathy.
Hong L; Lai HL; Fang Y; Tao Y; Qiu Y
J Cell Biochem; 2018 Nov; 119(11):9519-9531. PubMed ID: 30129221
[TBL] [Abstract][Full Text] [Related]
10. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis.
Koitabashi N; Arai M; Kogure S; Niwano K; Watanabe A; Aoki Y; Maeno T; Nishida T; Kubota S; Takigawa M; Kurabayashi M
Hypertension; 2007 May; 49(5):1120-7. PubMed ID: 17372041
[TBL] [Abstract][Full Text] [Related]
11. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis.
Yoon PO; Lee MA; Cha H; Jeong MH; Kim J; Jang SP; Choi BY; Jeong D; Yang DK; Hajjar RJ; Park WJ
J Mol Cell Cardiol; 2010 Aug; 49(2):294-303. PubMed ID: 20430035
[TBL] [Abstract][Full Text] [Related]
12. Studying the CCN Proteins in Fibrosis.
Hutchenreuther J; Leask A; Thompson K
Methods Mol Biol; 2017; 1489():423-429. PubMed ID: 27734394
[TBL] [Abstract][Full Text] [Related]
13. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
14. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
Borkham-Kamphorst E; van Roeyen CR; Van de Leur E; Floege J; Weiskirchen R
J Cell Commun Signal; 2012 Mar; 6(1):11-25. PubMed ID: 21748432
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation.
Rayego-Mateos S; Morgado-Pascual JL; Rodrigues-Diez RR; Rodrigues-Diez R; Falke LL; Mezzano S; Ortiz A; Egido J; Goldschmeding R; Ruiz-Ortega M
J Pathol; 2018 Feb; 244(2):227-241. PubMed ID: 29160908
[TBL] [Abstract][Full Text] [Related]
17. Protocol for CRISPR/Cas Genome Editing for Investigating Cell Communication Network.
Okusha Y; Eguchi T
Methods Mol Biol; 2023; 2582():157-167. PubMed ID: 36370349
[TBL] [Abstract][Full Text] [Related]
18. CCN5 attenuates profibrotic phenotypes of fibroblasts through the Smad6-CCN2 pathway: Potential role in epidural fibrosis.
Xu H; Liu C; Sun Z; Guo X; Zhang Y; Liu M; Li P
Int J Mol Med; 2015 Jul; 36(1):123-9. PubMed ID: 25901787
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor regulates retinal neovascularization through p53 protein-dependent transactivation of the matrix metalloproteinase (MMP)-2 gene.
Chintala H; Liu H; Parmar R; Kamalska M; Kim YJ; Lovett D; Grant MB; Chaqour B
J Biol Chem; 2012 Nov; 287(48):40570-85. PubMed ID: 23048035
[TBL] [Abstract][Full Text] [Related]
20. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
